Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2010 (2010), Article ID 172484, 9 pages
http://dx.doi.org/10.1155/2010/172484
Research Article

A s n 1 2 and A s n 2 7 8 : Critical Residues for In Vitro Biological Activity of Reteplase

1Clone Development Team, Lupin Limited, Biotechnology R & D, Gat #1156, Mulshi Taluka, Ghotawade Village, Pune 411042, India
2Analytical Development Team, Lupin Limited, Biotechnology R & D, Gat #1156, Mulshi Taluka, Ghotawade Village, Pune 411042, India
3Mammalian Bioassay Team, Lupin Limited, Biotechnology R & D, Gat #1156, Mulshi Taluka, Ghotawade Village, Pune 411042, India
4Lupin Limited, Biotechnology R & D, Gat #1156, Mulshi Taluka, Ghotawade Village, Pune 411042, India

Received 23 January 2010; Accepted 25 May 2010

Academic Editor: Henny H. Billett

Copyright © 2010 Naganath Mandi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Naganath Mandi, Kalyana R. Sundaram, Sunil K. Tandra, Suman Bandyopadhyay, and Sriram Padmanabhan, “ and : Critical Residues for In Vitro Biological Activity of Reteplase,” Advances in Hematology, vol. 2010, Article ID 172484, 9 pages, 2010. doi:10.1155/2010/172484